AbbVie | ABBV - 資産





資産 変化する 日付
AbbVie USD 135.12B 1.35B 2026-06
Abbott USD 110.43B 23.72B 2026-03
ALKERMES USD 4.39B 135.05M 2026-06
Amgen USD 92.5B 1.92B 2026-03
AstraZeneca USD 115.83B 1.82B 2026-06
Biogen USD 32.09B 2.6B 2026-06
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Coherus Biosciences USD 258.34M 258.18M 2025-12
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 116.58B 4.1B 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
J&J USD 201.06B 167M 2026-06
Medtronic USD 91.48B 139M 2025-12
Merck USD 128.68B 8.18B 2026-03
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 7.98B 551.9M 2026-03
Pfizer USD 201.13B 6.49B 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
UCB EUR 18.16B 971M 2025-12
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
United Therapeutics USD 6.71B 1.17B 2026-03
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06
Zoetis USD 15.15B 313M 2026-03